---
title: "Natural Alternatives International, Inc. Announces 2026 Q3 and YTD Results | NAII Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286893119.md"
description: "Natural Alternatives International, Inc. Announces 2026 Q3 and YTD Results | NAII Stock News"
datetime: "2026-05-19T02:15:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286893119.md)
  - [en](https://longbridge.com/en/news/286893119.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286893119.md)
---

# Natural Alternatives International, Inc. Announces 2026 Q3 and YTD Results | NAII Stock News

Natural Alternatives International, Inc. Announces 2026 Q3 and YTD Results | NAII Stock News

### Related Stocks

- [NAII.US](https://longbridge.com/en/quote/NAII.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)

## Related News & Research

- [NeOnc Advances Glioma Programs and Strengthens Financial Position](https://longbridge.com/en/news/286826865.md)
- [Acrivon Therapeutics, Inc. (ACRV) Receives a Buy from Oppenheimer](https://longbridge.com/en/news/286428001.md)
- [Eton Secures U.S. IMPAVIDO Rights; $4.25M Fees, Up To $4M Milestones And 50-55% Revenue Share](https://longbridge.com/en/news/286966420.md)
- [MIRA Pharmaceuticals Reports Positive Phase 1 Ketamir-2 Results](https://longbridge.com/en/news/286319406.md)
- [Sanofi says rare lung disease drug outperforms standard care in trial](https://longbridge.com/en/news/286810610.md)